Slingsby Brian Taylor
SEC insider (Form 3/4/5 filer). CIK 0001963901. Director at Mineralys Therapeutics, Inc. (MLYS). 11 reported Form 4/5 transactions since Sep 2024; latest on Sep 22, 2026. Located in SEATTLE, WA.
Companies Slingsby Brian Taylor has filed insider reports for
- Mineralys Therapeutics, Inc. (MLYS): Director
Slingsby Brian Taylor
CIK: 0001963901
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Mineralys Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Sep 22, 2026MLYS
Mineralys Therapeutics, Inc.
SaleIndirect104.3K shares at avg. $28.81$3.0M - Feb 19, 2026MLYS
Mineralys Therapeutics, Inc.
AwardDirect6.2K shares- - Feb 19, 2026MLYS
Mineralys Therapeutics, Inc.
OtherDirect6.2K shares- - Feb 19, 2026MLYS
Mineralys Therapeutics, Inc.
OtherIndirect6.2K shares- - Nov 20, 2025MLYS
Mineralys Therapeutics, Inc.
SaleIndirect1M shares at avg. $43.35$43.4M - Mar 13, 2025MLYS
Mineralys Therapeutics, Inc.
PurchaseIndirect259.3K shares at avg. $13.50$3.5M - Feb 13, 2025MLYS
Mineralys Therapeutics, Inc.
AwardDirectStock Option
32.9K shares- - Feb 13, 2025MLYS
Mineralys Therapeutics, Inc.
OtherDirectStock Option
32.9K shares- - Feb 13, 2025MLYS
Mineralys Therapeutics, Inc.
OtherIndirectStock Option
32.9K shares- - May 22, 2024MLYS
Mineralys Therapeutics, Inc.
OtherDirectStock Option
22K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 22, 2026 | MLYS Mineralys Therapeutics, Inc. | Sale | 104,320 | $28.81 | $3,005,303 | Indirect |
| Feb 19, 2026 | MLYS Mineralys Therapeutics, Inc. | Award | 6,200 | - | $0 | Direct |
| Feb 19, 2026 | MLYS Mineralys Therapeutics, Inc. | Other | 6,200 | - | $0 | Direct |
| Feb 19, 2026 | MLYS Mineralys Therapeutics, Inc. | Other | 6,200 | - | $0 | Indirect |
| Nov 20, 2025 | MLYS Mineralys Therapeutics, Inc. | Sale | 1,000,000 | $43.35 | $43,350,000 | Indirect |
| Mar 13, 2025 | MLYS Mineralys Therapeutics, Inc. | Purchase | 259,259 | $13.50 | $3,499,997 | Indirect |
| Feb 13, 2025 | MLYS Mineralys Therapeutics, Inc. | Award Stock Option | 32,900 | - | - | Direct |
| Feb 13, 2025 | MLYS Mineralys Therapeutics, Inc. | Other Stock Option | 32,900 | - | - | Direct |
| Feb 13, 2025 | MLYS Mineralys Therapeutics, Inc. | Other Stock Option | 32,900 | - | - | Indirect |
| May 22, 2024 | MLYS Mineralys Therapeutics, Inc. | Other Stock Option | 22,000 | - | - | Direct |
1-10 of 11 transactions